Beneficial effects of bardoxolone methyl, an Nrf2 activator, on crush-related acute kidney injury in rats
- PMID: 31471671
- DOI: 10.1007/s00068-019-01216-z
Beneficial effects of bardoxolone methyl, an Nrf2 activator, on crush-related acute kidney injury in rats
Abstract
Purpose: The purpose of this study was to investigate the effects of bardoxolone methyl (BM), a nuclear factor erythroid 2-related factor 2 (Nrf2) activator, on acute kidney injury in a rat model of crush syndrome model.
Methods: Sixty-four rats were separated equally into eight groups, sham (sterile saline ip), crush, crush + vehicle (DMSO ip), and crush + BM (10 mg/kg ip) (n = 8). All groups were also divided as 3 and 24 h after decompression. Crush injury was induced by 6 h of direct compression to both hind limbs of the rats with blocks weighing 3.6 kg on each side, followed by 3 and 24 h of decompression. Kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), tumor necrotizing factor-α (TNF-α), transforming growth factor-β1 (TGF-β1) concentrations, tissue total oxidant status (TOS) and total antioxidant status (TAS) were measured in the kidneys. Serum creatine kinase (CK), blood urea nitrogen (BUN) and creatinine concentrations were also measured. Glomerular and tubular structures were examined histopathologically. Bcl-2 was measured using immunohistochemistry. Apoptosis was assessed using the TUNEL method.
Results: BM treatment reduced KIM-1, NGAL, TNF-α, TGF-β1, TOS concentrations, and increased TAS concentrations in the kidneys 3 and 24 h after decompression. Serum CK, BUN and creatinine concentrations were also reduced with BM. BM treatment decreased apoptosis in crush-related AKI. The Nrf2 activator BM reversed the crush-induced changes in the experimental rats.
Conclusion: BM treatment prevented the progression of crush-related AKI in rats possibly through its cytoprotective effects of being an antioxidant, anti-inflammatory and anti-apoptotic agent.
Keywords: Acute kidney injury; Bardoxolone methyl; Crush syndrome; Nrf2.
References
-
- Sever MS, Vanholder R, Ashkenazi I, Becker G, Better O, Covic A, De Smet M, Eckardt KU, Eknoyan G, Gibney N, Hoste E, Kazancioglu R, Lameire N, Luyckx V, Portilla D, Tuglular S, Van Biesen W. Recommendation for the management of crush victims in mass disasters. Nephrol Dial Transpl. 2012;27(Suppl 1):i1–67.
-
- Sever MS, Kellum J, Hoste E, Vanholder R. Application of the RIFLE criteria in patients with crush-related acute kidney injury after mass disasters. Nephrol Dial Transplant. 2011;26(2):515–24. - PubMed
-
- Murata I, Ooi K, Shoji S, Motohashi Y, Kan M, Ohtake K, Kimura S, Ueda H, Nakano G, Sonoda K, Inoue Y, Uchida H, Kanamoto I, Morimoto Y, Kobayashi J. Acute lethal crush-injured rats can be successfully rescued by a single injection of high-dose dexamethasone through a pathway involving PI3K-Akt-eNOS signaling. J Trauma Acute Care Surg. 2013;75:241–9. - PubMed
-
- Murata I, Nozaki R, Ooi K, Ohtake K, Kimura S, Ueda H, Nakano G, Sonoda K, Inoue Y, Uchida H, Kanamoto I, Morimoto Y, Kobayashi J. Nitrite reduces ischemia/reperfusion-induced muscle damage and improves survival rates in rat crush injury model. J Trauma Acute Care Surg. 2012;72(6):1548–54. - PubMed
-
- Sgarbi MW, Silva BA Jr, Peres CM, Alba TC, Curi R, Soriano FG, Ribeiro DA, Velasco IT. Leukocyte infiltration in lung, muscle, and liver after limb compression in rats. Pathophysiology. 2013;20(2):111–6. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
